RxDoctor Payments Data

Robert Skalicky, DO

Plastic Surgery · Newtown, PANPI 1134182231

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,408 of the $9,479 with a category attached, or 78.1%. 12 manufacturers reported payments, led by AbbVie at 35.3% of the total. Reporting peaked in 2019 at $4,260 and has fallen 60.1% since, to $1,700 in 2025.

$9,479in general payments, 2019–2025

Across 191 payments — averaging $49.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Merz North America, Inc.$2K
  • Revance Therapeutics, Inc.$2K
  • Mentor Worldwide LLC$1K
  • Galderma Laboratories, L.p.$347
  • Coopersurgical, Inc.$345
  • plus $406 from 6 others

What the payments were for

  • Food & beverage$7,40878%
  • Education$170%
  • Gifts$2,05422%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,479 in reported general payments places this provider in the 80th percentile of 196 plastic surgery providers in Pennsylvania.

See all plastic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$9,456
Medicare patients
12
Services billed
35

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin74$354
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen60$211
Scopolamine16$209
Clindamycin Hcl12$67
ValacyclovirValacyclovir Hcl15$56
Alprazolam42$54

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Newtown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →